Row
I
IMVTAI Stock Diagnostic Report
Immunovant director Atul Pande sells $59,699 in shares
Atul Pande, a director of Immunovant, has sold shares of the company.
View Source Article ↗AI CATALYST SCORE40 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
IMVT Analysis History (Last 30 Days)